UK scientists developing Ebola vaccine that could be ready for trials in months
The rare species of Ebola, known as Bundibugyo, for which there is no proven vaccine, kills around a third of those infected. - Kenya breaking news | Kenya news today | Capitalfm.co.ke..
✨ Key Highlights
UK scientists at Oxford University are rapidly developing an experimental Ebola vaccine, potentially ready for clinical trials in two to three months, to combat the current outbreak in the Democratic Republic of Congo.
- The outbreak has caused 750 suspected cases and 177 deaths.
- The vaccine utilizes the same adaptable ChAdOx1 technology previously used for Covid-19.
- This new vaccine targets the rare Bundibugyo species of Ebola, for which no proven vaccine currently exists, though the World Health Organization (WHO) has noted a lack of animal data supporting its effectiveness yet.
Continue Reading
Read the complete article from Capital News
Part of the Day's Coverage
Kenya on High Alert After Suspected Ebola Cases Emerge - May 2026
Health Cabinet Secretary Aden Duale announced that Kenya has no confirmed cases of the Ebola virus following fears of an outbreak, with all suspected individuals testing negative. However, Duale put 22 counties on high-risk alert. UK scientists at Oxford University are rapidly developing an experimental Ebola vaccine, potentially ready for clinical trials in two to three months, to combat the current outbreak in the Democratic Republic of Congo. In the DRC, an angry crowd set fire to tents used as isolation wards at a hospital in eastern DRC after being prevented from taking the body of a suspected Ebola victim for burial.
